Kiwa Bio-Tech Products Group Corporation
KWBT · OTC
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.25 | 0.02 | -0.04 |
| FCF Yield | 40.12% | -20.60% | -27.33% | -20.59% |
| EV / EBITDA | -2.82 | 3.66 | 9.42 | 5.04 |
| Quality | ||||
| ROIC | -12.58% | 2.82% | 6.48% | -16.10% |
| Gross Margin | 23.28% | 26.94% | 31.41% | 20.22% |
| Cash Conversion Ratio | -0.03 | -4.80 | -6.94 | -1.19 |
| Growth | ||||
| Revenue 3-Year CAGR | 32.41% | 47.16% | – | – |
| Free Cash Flow Growth | 110.76% | 70.27% | -368.43% | -713.58% |
| Safety | ||||
| Net Debt / EBITDA | -2.43 | 0.51 | 0.00 | 1.34 |
| Interest Coverage | -0.30 | 4.08 | 3.43 | 7.06 |
| Efficiency | ||||
| Inventory Turnover | 976.23 | 13.63 | 4.31 | 0.00 |
| Cash Conversion Cycle | 18.87 | 80.91 | 30.14 | -81.18 |